https://www.reuters.com/legal/ex-coinbase-managers-brother-sentenced-10-months-insider-trading-case-2023-01-10/
HC Wainwright & Co. Maintains Buy on Freeline Therapeutics, Lowers Price Target to $15
HC Wainwright & Co. analyst Patrick Trucchio maintains Freeline Therapeutics (NASDAQ:FRLN) with a Buy and lowers the price target from $20 to $15.